IOBT - IO Biotech, Inc.

QQQ $ 439.94 $ 1.71 (0.39 %)

DIA $ 389.73 $ 1.44 (0.37 %)

SPY $ 516.86 $ 1.61 (0.31 %)

TLT $ 90.38 $ 0.07 (0.08 %)

GLD $ 214.54 $ 0.92 (0.43 %)

Previous Close

$ 1.54

Open

$ 1.48

Bid

$ 0.00 x 0

Ask

$ 1.58 x 100

Day's Range

$ 1.48 - $ 1.48

52 Week Range

$ 0.82 - $ 2.29

Volume

67,465

Average Volume

Market Cap

67.05M

Beta (5Y Monthly)

$ 1.17

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-05-2024	12-31-2023	10-K
2	11-13-2023	09-30-2023	10-Q
3	08-11-2023	06-30-2023	10-Q
4	05-11-2023	03-31-2023	10-Q
5	03-14-2023	12-31-2022	10-K
6	11-09-2022	09-30-2022	10-Q
7	08-11-2022	06-30-2022	10-Q
8	05-16-2022	03-31-2022	10-Q
9	03-31-2022	12-31-2021	10-K
10	12-17-2021	09-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

IO Biotech Presents New Data For Cancer Va...
04/09/2024 16:05:40

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
03/06/2024 21:31:05

HC Wainwright & Co. Reiterates Buy on IO B...
03/06/2024 13:21:23

HC Wainwright & Co. analyst Emily Bodnar reiterates IO Biotech (NASDAQ:IOBT) with a Buy and maintains $8 price target.

IO Biotech Q4 EPS $(0.40) Misses $(0.39) E...
03/05/2024 21:43:06

IO Biotech (NASDAQ:IOBT) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.39) ...

top-5-health-care-stocks-that-may-crash-this-month

Top 5 Health Care Stocks That May Crash Th...
01/22/2024 12:34:46

As of Jan. 22, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as ...

IO Biotech Announces First Patient Dosed I...
12/21/2023 13:32:44

IO Biotech (NASDAQ:IOBT), a clinical-stage biopharmaceutical company developing novel, immune modulating therapeutic cancer vac...

why-anavex-life-sciences-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Anavex Life Sciences Shares Are Tradin...
11/27/2023 18:41:21

Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quart...

io-biotech-and-2-other-stocks-under-2-insiders-are-buying

IO Biotech And 2 Other Stocks Under $2 Ins...
11/27/2023 11:26:48

The Dow Jones closed higher by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence ...

IO Biotech Q3 EPS $(0.43) Beats $(0.44) Es...
11/13/2023 13:43:40

IO Biotech (NASDAQ:IOBT) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.44) by...

IO Biotech: Q3 Earnings Insights
11/13/2023 13:15:06

IO Biotech Completes Enrollment Pf 380 Pat...
11/10/2023 13:01:14

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
10/24/2023 21:31:31

IO Biotech Announced Preliminary Data From...
10/23/2023 06:09:02

IO Biotech Announces Upcoming Poster Prese...
10/03/2023 20:38:12

Expert Ratings for IO Biotech
09/28/2023 15:00:51

Benzinga's Top Ratings Upgrades, Downgrade...
09/28/2023 15:00:45

Piper Sandler Initiates Coverage On IO Bio...
09/28/2023 11:17:21

Piper Sandler analyst Christopher Raymond initiates coverage on IO Biotech (NASDAQ:IOBT) with a Overweight rating and announ...

HC Wainwright & Co. Reiterates Buy on IO B...
09/13/2023 10:31:08

HC Wainwright & Co. analyst Emily Bodnar reiterates IO Biotech (NASDAQ:IOBT) with a Buy and maintains $8 price target.

IO Biotech Announces Presentation Of New D...
09/12/2023 12:10:53

Morgan Stanley Maintains Overweight on IO ...
08/15/2023 13:00:37

Morgan Stanley analyst Matthew Harrison maintains IO Biotech (NASDAQ:IOBT) with a Overweight and lowers the price target fro...